|
Novel Gene Networks in Breast Development and Cancer
|
5P01CA030195-25
|
$2,383,667
|
$953,467
|
Oesterreich, Steffi
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
1P30CA125123-01
|
$1,500,000
|
$60,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-01S1
|
$111,700
|
$4,468
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Biology and Diagnosis of HNPCC
|
5R01CA072851-12
|
$326,412
|
$163,206
|
BOLAND, Clement
|
BAYLOR RESEARCH INSTITUTE
|
|
Space-Time Technology for Reconstructing Exposure in Cancer Epidemiology Studies
|
1R43CA132341-01
|
$99,999
|
$99,999
|
Jacquez, Geoffrey
|
BIOMEDWARE
|
|
SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) EXPANSION PROGRAM
|
N01PC544002-007
|
$1,756,938
|
$878,469
|
CHEN, VIVIEN
|
BOARD OF SUPERVISORS OF LA STATE UNIV
|
|
Modification of tamoxifen effectiveness by gene polymorphisms and other drugs
|
5R01CA118708-02
|
$234,985
|
$234,985
|
LASH, TIMOTHY
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Gene Polymorphisms in Relation to Cancer in Black Women
|
5R01CA098663-05
|
$545,653
|
$272,827
|
PALMER, JULIE
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Case-Control Surveillance of Serious Illnesses and Drugs
|
5R01CA045762-18
|
$793,862
|
$793,862
|
Rosenberg, Lynn
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Meningioma: Risk Factors and Quality of Life
|
5R01CA109461-02
|
$223,524
|
$111,762
|
BLACK, PETER
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Women's Health Study: Continued Follow-up
|
5R01CA047988-17
|
$1,666,176
|
$833,088
|
BURING, JULIE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genome Wide Association Study: Variants Influencing Steroid Hormone Levels
|
1R03CA128034-01A1
|
$87,500
|
$87,500
|
Cox, David
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Mitochondrial Haplogroups and Breast Cancer Risk
|
1R03CA130050-01
|
$87,500
|
$87,500
|
Cox, David
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genes, Hormones & Environment in an Ovarian Cancer Model
|
5R01CA054419-15
|
$792,972
|
$396,486
|
CRAMER, DANIEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Partners Southwestern Clinical Epidemiology/Validation
|
5U01CA086381-08
|
$861,745
|
$861,745
|
CRAMER, DANIEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic Susceptibility to Endometrial Cancer
|
5R01CA082838-08
|
$331,803
|
$331,803
|
DEVIVO, IMMACULATA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Prospective Study of DNA Repair Gene Variants in Breast Cancer
|
1R01CA118447-01A1
|
$331,008
|
$331,008
|
HAN, JIALI
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic Variants in Pigmentation Genes and Skin Cancer Risk
|
1R03CA128080-01
|
$87,500
|
$87,500
|
HAN, JIALI
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic Variants in Immunological Mediator Genes and Skin Cancer Risk
|
1R03CA132175-01
|
$86,936
|
$58,247
|
HAN, JIALI
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Dietary and Hormonal Determinants of Cancer in Women
|
5P01CA087969-08
|
$4,773,855
|
$4,773,855
|
HANKINSON, SUSAN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Biochemical Markers in the nurses' Health Study Cohort
|
5R01CA049449-18
|
$1,203,783
|
$963,026
|
Hankinson, Susan
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cohort Study of Genetic Susceptibility to Breast Cancer
|
2R01CA065725-11A1
|
$405,093
|
$405,093
|
HUNTER, David
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3
|
2U01CA098233-05
|
$1,331,791
|
$665,896
|
HUNTER, David
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
SPORE in Skin Cancer
|
3P50CA093683-05S2
|
$512,285
|
$102,457
|
KUPPER, THOMAS
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Nutiritional and Biochemical/Genetic Markers of Cancer
|
5R01CA042182-20
|
$714,410
|
$714,410
|
Ma, Jing
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Allergies, Genetic Susceptibility and Adult Glioma Risk
|
5R01CA114205-02
|
$399,509
|
$399,509
|
MICHAUD, DOMINIQUE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Lifetime body weight and premenopausal breast cancer
|
5R01CA114326-02
|
$193,715
|
$96,858
|
MICHELS, KARIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Nitric Oxide Synthase Polymorphisms and Risk for Skin Cancer
|
1R03CA130055-01
|
$87,500
|
$87,500
|
QURESHI, ABRAR
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
"Molecular Signatures of Lethal and Indolent Prostate Cancer"
|
5R01CA116337-02
|
$508,718
|
$508,718
|
RUBIN, MARK
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Clock Genes, Night Work, and Breast Cancer Risk
|
5R01CA114534-02
|
$271,455
|
$135,728
|
SCHERNHAMMER, EVA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Benign Breast Disease and Risk of Breast Cancer
|
5R01CA046475-16
|
$340,162
|
$340,162
|
TAMIMI, RULLA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
The Role of Prolactin in the Etiology of Postmenopausal Breast Cancer
|
5R01CA119139-02
|
$226,000
|
$226,000
|
Tworoger, Shelley
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cysteine, Related Gene Variants and Breast Cancer Risk
|
1R01CA124857-01A1
|
$325,802
|
$162,901
|
Willett, Walter
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Estrogen and Progesterone-related Gene Variants and Colorectal Cancer Risk
|
5R01CA123089-02
|
$304,763
|
$228,572
|
ZHANG, SHUMIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
The Boston Collaborative Oral Cancer Study
|
7R01CA078609-08
|
$180,058
|
$180,058
|
Kelsey, Karl
|
BROWN UNIVERSITY
|
|
Microsatellite instability and cancer gene expression
|
5R01CA098818-05
|
$405,062
|
$101,266
|
PERUCHO, MANUEL
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
MOLECULAR PATHOGENESIS OF CANCER OF MUTATOR PHENOTYPE
|
5R37CA063585-15
|
$802,240
|
$401,120
|
PERUCHO, MANUEL
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA030199-27
|
$3,387,817
|
$101,635
|
VUORI, KRISTIINA
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
Ontario Familial Breast Cancer Registry
|
5U01CA069467-13
|
$708,711
|
$708,711
|
ANDRULIS, IRENE
|
CANCER CARE ONTARIO
|
|
Ontario Registry for Studies of Familial Colon Cancer
|
3U01CA074783-09S1
|
$1,607,496
|
$803,748
|
GALLINGER, STEVEN
|
CANCER CARE ONTARIO
|
|
Case Comprehensive Cancer Center Support Grant
|
2P30CA043703-18
|
$5,104,000
|
$102,080
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Design and Inference for Hybrid Ecological Studies
|
1R01CA125081-01
|
$196,588
|
$25,556
|
HANEUSE, SEBASTIEN
|
CENTER FOR HEALTH STUDIES
|
|
Multi-Center Study of Pancratic Cancer Etiology
|
5R01CA102765-04
|
$1,131,891
|
$282,973
|
POTTER, JOHN
|
CENTER FOR HEALTH STUDIES
|
|
Assessing the Impact of Colorectal Cancer Screening
|
5U01CA097427-06
|
$213,789
|
$213,789
|
RUTTER, CAROLYN
|
CENTER FOR HEALTH STUDIES
|
|
GENOMIC ANALYSIS OF MEDULLOBLASTOMAS
|
5R01CA109467-04
|
$740,333
|
$740,333
|
POMEROY, SCOTT
|
CHILDREN'S HOSPITAL BOSTON
|
|
Molecular Studies of Down Syndrome Leukemia
|
5R01CA111778-03
|
$231,698
|
$115,849
|
PERENTESIS, JOHN
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
GENETIC PREDICTORS OF LEUKEMIA THERAPY RESPONSE
|
5R01CA108862-03
|
$256,930
|
$256,930
|
Aplenc, Richard
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
CONTROL SELECTION METHODS FOR CHILDHOOD CANCER STUDIES
|
5R01CA108934-02
|
$374,780
|
$374,780
|
BUNIN, GRETA
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Ethnic Differences in Survival after Childhood ALL
|
5R01CA096670-04
|
$485,753
|
$485,753
|
BHATIA, SMITA
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA033572-24S1
|
$61,920
|
$2,477
|
KRONTIRIS, THEODORE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
Total relevant funding to Biochemical Epidemiology for this search: $199,701,579
|